The 8th Myeloma and Lymphoma International Conference in Kraków 2019 (former “Complex treatment of plasma cell dyscrasia”) is a traditional scientific meeting organized in Cracow by the Department of Haematology Jagiellonian University, Myeloma Treatment Foundation Centre and Cracow Branch of the Polish Society of Hematology and Transfusion Medicine. Program of the Conference focuses on interdisciplinary and multimodal therapy of patients with lymphoma, amyloidosis, multiple myeloma and Waldenström’s disease.
Actually invitation to Małopolska has been accepted by outstanding specialists from the United States, Germany, Italy and Turkey, which confirms that medicine knows no borders and that mutual intellectual stimulation is above any national differences. We are delighted to host such widely recognized researchers in Cracow, the location of the oldest haematological centre In Poland. We hope that our Guests will have an opportunity to enjoy the beauty of the historical capital of Poland, and to visit a unique site, the Benedictine Abbey in Tyniec.
We would like to thank Amgen Biotechnologia Sp. z o.o., Celgene Sp. z o.o., Karyopharm, Takeda Polska Sp. z o.o., Roche Polska Sp z. o.o., Janssen-Cilag Polska Sp. z o.o. and Sanofi-Aventis Sp. z o.o. for supporting us in organization of this Conference.
We hope that this meeting will contribute to the development of modern treatment of lymphoma and plasma cell dyscrasia in Poland, where many innovative therapies are still not reimbursed. We provide for all guests accommodation in Krakow and other activities in the conference. Please sign up through the page www.szpiczak2019.pl
Artur Jurczyszyn, M.D., Ph.D., Assoc. Professor
Professor Wojciech Jurczak, M.D., Ph.D.